Investigación / Grupos de investigación

Grupo  3

Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Publicaciones (589)

  • Wolff, D; Cutler, C; Lee, SJ; Pusic, I; Bittencourt, H; White, J; Hamadani, M; Arai, S; Salhotra, A; Perez-Simon, JA; Alousi, A; Choe, H; Kwon, M; Bermudez, A; Kim, I; Socie, G; Chhabra, S; Radojcic, V; O'Toole, T; Tian, C; Ordentlich, P; Defilipp, Z; Kitko, CL.

    Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease

    NEW ENGLAND JOURNAL OF MEDICINE. 2024; 391(11): 1002-1014 Nº de citas: 43 [doi:10.1056/NEJMoa2401537]

  • Arguello-Tomas, M; Mozas, P; Albiol, N; López-Esteban, M; Sierra, J; Nomdedéu, J; Martinez-Laperche, C; Moga, E; Piñeyroa, JA; Delgado, J; Osorio, S; Moreno, C.

    Risk scores predicting disease progression in early-stage CLL: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy

    CANCER. 2024; 131(1): [doi:10.1002/cncr.35552]

  • Delgado-Wicke P; Fernández de Córdoba-Oñate S; Roy-Vallejo E; Alegría-Carrasco E; Rodríguez-Serrano DA; Lamana A; Montes N; Nicolao-Gómez A; Carracedo-Rodríguez R; Marcos-Jiménez A; Díaz-Fernández P; Galván-Román JM; Rabes-Rodríguez L; Sanz-Alba M; Álvarez-Rodríguez J; Villa-Martí A; Rodríguez-Franco C; Villapalos-García G; Zubiaur P; Abad-Santos F; de Los Santos I; Gomariz RP; García-Vicuña R; Muñoz-Calleja C; González-Álvaro I; Fernández-Ruiz E.

    Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables.

    Scientific Reports. 2024; 14(1): 20728-20728 Nº de citas: 7 [doi:10.1038/s41598-024-71476-2]

  • Mingot-Castellano, ME; Reguera-Ortega, JL; Torres, DZ; Hernani, R; Lopez-Godino, O; Guerreiro, M; Herrero, B; López-Corral, L; Luna, A; Gonzalez-Pinedo, L; Chinea-Rodriguez, A; Africa-Martín, A; Bailen, R; Martinez-Cibrian, N; Balsalobre, P; Filaferro, S; Alonso-Saladrigues, A; Barba, P; Perez-Martinez, A; Calbacho, M; Perez-Simón, JA; Sánchez-Pina, JM.

    Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients

    Journal of Clinical Medicine. 2024; 13(17): Nº de citas: 3 [doi:10.3390/jcm13175117]

  • Gómez-Centurión, I; Morillo, AIG; Martínez, AP; Calvo, MC; Chinea, A; González, L; Pedraza, A; Lorenzo, MJJ; Robles, MC; Bailén, R; Cascón, MJP; Cabero, A; Sánchez, JLP; Luna, A; Alvarez, MP; Rovira, M; Catarineu, AT; Sanchez-Pina, J; Kwon, M.

    Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Study on Behalf of the Spanish Hematopoietic Stem Cell Transplantation and Cellular (GETH)

    Transplantation And Cellular Therapy. 2024; 30(9): 1-8 Nº de citas: 1 [doi:10.1016/j.jtct.2024.06.003]

  • Hübel, K; Bower, M; Aurer, I; Bastos-Oreiro, M; Besson, C; Brunnberg, U; Cattaneo, C; Collins, S; Cwynarski, K; Pria, AD; Hentrich, M; Hoffmann, C; Kersten, MJ; Montoto, S; Navarro, JT; Oksenhendler, E; Re, A; Ribera, JM; Schommers, P; von Tresckow, B; Buske, C; Dreyling, M; Davies, A.

    Human immunodeficiency virus-associated Lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    Hemasphere. 2024; 8(9): Nº de citas: 3 [doi:10.1002/hem3.150]

  • Muñiz, P; Martínez-García, M; Bailén, R; Chicano, M; Oarbeascoa, G; Trivino, JC; Sebastian, ID; de Córdoba, SF; Anguita, J; Kwon, M; Díez-Martín, JL; Olmos, PM; Martínez-Laperche, C; Buño, I.

    Identification of predictive models including polymorphisms in cytokines genes and clinical variables associated with post-transplant complications after identical HLA-allogeneic stem cell transplantation

    Frontiers in Immunology. 2024; 15: Nº de citas: 1 [doi:10.3389/fimmu.2024.1396284]

  • Fernández, CM; Sebio, A; Rincón, JO; Broto, JM; Benlloch, AM; Plaza, DM; Pousa, AL; Alegría, IG; Giuppi, M; Ballesteros, EC; Bernabeu, D; de Alava, E; Morales, CV.

    Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS)

    CLINICAL & TRANSLATIONAL ONCOLOGY. 2024; 27(3): 824-836 Nº de citas: 2 [doi:10.1007/s12094-024-03602-5]

  • Nagler, A; Labopin, M; Swoboda, R; Blaise, D; Angelucci, E; Vydra, J; Corral, LL; Bramanti, S; Chiusolo, P; Kwon, M; Koc, Y; Itaela-Remes, M; Martino, M; Kulagin, A; Busca, A; Ciceri, F; Mohty, M.

    Young (<35 years) haploidentical versus old (=35 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

    BONE MARROW TRANSPLANTATION. 2024; 59(11): 1552-1562 Nº de citas: 4 [doi:10.1038/s41409-024-02400-5]

  • Sesques, P; Kirkwood, AA; Kwon, M; Rejeski, K; Jain, MD; Di Blasi, R; Brisou, G; Gros, FX; le Bras, F; Bories, P; Choquet, S; Rubio, MT; Iacoboni, G; O'Reilly, M; Casasnovas, RO; Bay, JO; Mohty, M; Joris, M; Abraham, J; Llorente, CC; Loschi, M; Carras, S; Chauchet, A; La Rochelle, LD; Hermine, O; Guidez, S; Cony-Makhoul, P; Fogarty, P; Le Gouill, S; Morschhauser, F; Gastinne, T; Cartron, G; Subklewe, M; Locke, FL; Sanderson, R; Barba, P; Houot, R; Bachy, E.

    Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma

    JOURNAL OF HEMATOLOGY & ONCOLOGY. 2024; 17(1): [doi:10.1186/s13045-024-01579-w]

  • Wlodarski, MW; Vlachos, A; Farrar, JE; Da Costa, LM; Kattamis, A; Dianzani, I; Belendez, C; Unal, S; Tamary, H; Pasauliene, R; Pospisilova, D; de la Fuente, J; Iskander, D; Wolfe, L; Liu, JM; Shimamura, A; Albrecht, K; Lausen, B; Bechensteen, AG; Tedgard, U; Puzik, A; Quarello, P; Ramenghi, U; Bartels, M; Hengartner, H; Farah, RA; Al Saleh, M; Hamidieh, AA; Yang, W; Ito, E; Kook, H; Ovsyannikova, G; Kager, L; Gleizes, PE; Dalle, JH; Strahm, B; Niemeyer, CM; Lipton, JM; Leblanc, TM.

    Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement

    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2024; 154(2): 368-382 Nº de citas: 11

  • López-Carrasco, A; Vieco-Marti, I; Granados-Aparici, S; Acevedo-León, D; Estañ-Capell, N; Portugal, R; Huerta-Aragonés, J; Cañete, A; Navarro, S; Noguera, R.

    Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker?

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(16): Nº de citas: 3 [doi:10.3390/ijms25168733]

  • de Frutos Porras, E; Cobo-Vázquez, E; Lobo, AH; del Mar Santos Sebastián, M; Fernández, EP; Colino, CG; Cela, E; Gómez, MLN.

    A Local Experience of Antibiotic Lock Therapy as an Adjunctive Treatment for Central Venous Catheter-Related Bloodstream Infections in Pediatric Oncology and Hematology Patients

    Children-Basel. 2024; 11(8): Nº de citas: 1 [doi:10.3390/children11080983]

  • Spanjaart, AM; Ljungman, P; Tridello, G; Schwartz, J; Martinez-Cibrian, N; Barba, P; Kwon, M; Lopez-Corral, L; Martinez-Lopez, J; Ferra, C; Di Blasi, R; Ghesquieres, H; Mutsaers, P; Calkoen, F; Jak, M; van Doesum, J; Vermaat, JSP; van der Poel, M; Maertens, J; Gambella, M; Metafuni, E; Ciceri, F; Saccardi, R; Nicholson, E; Tholouli, E; Matthew, C; Potter, V; Bloor, A; Besley, C; Roddie, C; Wilson, K; Nagler, A; Campos, A; Petersen, SL; Folber, F; Bader, P; Finke, J; Kroger, N; Knelange, N; de la Camara, R; Kersten, MJ; Mielke, S.

    Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group

    LEUKEMIA. 2024; 38(9): 1985-1991 Nº de citas: 4 [doi:10.1038/s41375-024-02336-1]

  • Bug, G; Labopin, M; Kulagin, A; Blaise, D; Raiola, AM; Vydra, J; Sica, S; Kwon, M; López-Corral, L; Bramanti, S; Borne, PV; Itälä-Remes, M; Martino, M; Koc, Y; Brissot, E; Giebel, S; Nagler, A; Ciceri, F; Mohty, M.

    Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT)

    BONE MARROW TRANSPLANTATION. 2024; 59(10): 1394-1401 [doi:10.1038/s41409-024-02331-1]

  • Iacoboni, G; Sánchez-Salinas, MA; Rejeski, K; Martín-López, AA; Kwon, M; Navarro, V; Jalowiec, KA; Hernani, R; Reguera-Ortega, JL; Gallur, L; Blumenberg, V; Herrero-García, M; Roddie, C; Benzaquén, A; Delgado-Serrano, J; Bailén, R; Carpio, C; Amat, P; López-Corral, L; Martín-Martín, L; Bastos, M; Subklewe, M; O'Reilly, M; Barba, P.

    Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cells

    Hemasphere. 2024; 8(7): Nº de citas: 3 [doi:10.1002/hem3.86]

  • van Besien, K; Liu, HT; Margevicius, S; Fu, PF; Artz, A; Chaekal, OK; Metheny, L; Shore, T; Kosuri, S; Mayer, S; Gomez-Arteaga, A; Kwon, M.

    Haplo-cord transplant. Realizing the potential of umbilical cord blood grafts. - A review of techniques and analysis of outcomes

    LEUKEMIA & LYMPHOMA. 2024; 65(10): 1384-1397 Nº de citas: 1 [doi:10.1080/10428194.2024.2361353]

  • Fox, ML; García-Cadenas, I; Navarro, V; Martínez, AP; Kara, M; Bazán, IS; Coll, CF; Bailén, R; Bento, L; Parody, R; Esquirol, A; Orti, G; Mussetti, A; Salamero, O; Martino, R; González, AP; Barba, P; Kwon, M; Solano, C; Bosch, F; Valcárcel, D.

    Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies

    BONE MARROW TRANSPLANTATION. 2024; 59(10): 1369-1375 [doi:10.1038/s41409-024-02322-2]